Nonlinear Metabolic Disposition of Theophylline
- 1 September 1984
- journal article
- research article
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 6 (3) , 290-297
- https://doi.org/10.1097/00007691-198409000-00006
Abstract
Eleven healthy volunteers were given maintenance treatment with oral theophylline, in increasing doses (210-1260 mg/day). Seven subjects took 4 different doses, 3 subjects took 3 doses and 1 subject discontinued treatment after only 2 doses. Plasma and urine were collected during a dose interval at steady state. Theophylline in plasma and urine and metabolites in urine (1-methyluric acid, 1-MU; 3-methylxanthine, 3-MX; 1,3-dimethyluric acid, DMU) were determined by high-performance liquid chromatography. Total clearance of theophylline, as well as clearances to all 3 metabolic products (but not theophylline renal clearance), decreased with increasing dose. The individual Michaelis-Menten parameters Km and Vmax could be estimated for 6 subjects who took all 4 doses. Considerable interindividual variability in these parameters, and particularly Km, was found. The Km for overall elimination averaged 133 .mu.mol/l (range 55-213 .mu.mol/l) and the Vmax averaged 611 .mu.mol/h (2640 mg/day; range 452-813 .mu.mol/h). With regard to individual metabolic routes, the Km for theophylline metabolism to 1-MU was 88 .+-. 41 (mean .+-. SD) .mu.mol/l and the Vmax was 110 .+-. 15 .mu.mol/h; the Km for metabolism to 3-MX was 90 .+-. 37 .mu.mol/l and the Vmax was 78 .+-. 13 .mu.mol/h; the Km for metabolism to DMU was 179 .+-. 92 .mu.mol/l and the Vmax was 357 .+-. 122 .mu.mol/h. The Km values for the N-demethylation pathways (1-MU and 3-MX) were significantly correlated (r = 0.95; P < 0.01). Nonlinear metabolic disposition of theophylline occurs, particularly by the 2 N-demethylation pathways, within recommended ranges of maintenance doses and steady-state concentrations. The interindividual variability in Michaelis-Menten parameters, particularly Km, is great. The clinical implication of these findings is that large changes in maintenance doses of theophylline should be performed with caution and should be accompanied by plasma concentration monitoring.This publication has 23 references indexed in Scilit:
- Influence of methylxanthine‐containing foods on theophylline metabolism and kineticsClinical Pharmacology & Therapeutics, 1979
- Theophylline Bioavailability following Chronic Dosing of an Elixir and Two Solid Dosage FormsJournal of Pharmaceutical Sciences, 1978
- Clinical Pharmacokinetics of TheophyllineClinical Pharmacokinetics, 1978
- Dose-dependent kinetics of theophylline disposition in asthmatic childrenThe Journal of Pediatrics, 1977
- Kinetics of intravenous theophyllineClinical Pharmacology & Therapeutics, 1977
- Renal Clearance of Theophylline in ManThe Journal of Clinical Pharmacology, 1976
- Pharmacokinetic analysis of the disposition of intravenous theophylline in young childrenThe Journal of Pediatrics, 1976
- A Comparison of Estimates of Michaelis-Menten Kinetic Constants from Various Linear TransformationsJournal of Biological Chemistry, 1965
- A STUDY OF THE METABOLISM OF THEOBROMINE, THEOPHYLLINE, AND CAFFEINE IN MANJournal of Biological Chemistry, 1957
- METABOLISM OF THEOPHYLLINE (1, 3-DIMETHYLXANTHINE) IN MANJournal of Biological Chemistry, 1952